Home linkHome link

Publications

You are currently filtering by: 2016 Cancer prostate

Cancer • 2016 • Fitoterapia 111: 66-72. PMID: 27102611.
Suppression of rat and human androgen biosynthetic enzymes by apigenin: Possible use for the treatment of prostate cancer.

Wang X, Wang G, Li X, Liu J, Hong T, Zhu Q, Huang P, Ge RH

Full Article
• 2016 • Oncotarget 7(42): 68650-68661. PMID: 27626681.
Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction.

Mathew SO, Chaudhary P, Powers SB, Vishwanatha JK, Mathew PA

Full Article

NDRI is a Not-For-Profit (501c3) Corporation.

National Disease Research Interchange logo
National Disease Research Interchange

Three Parkway
1601 Cherry Street, Suite 1700
Philadelphia, PA 19102

CAP Accredited Registered scientist.com supplier

General

info@ndriresource.org


Researchers

research@ndriresource.org

 

Privacy Policy

Main

(215) 557-7361

 

Toll-Free

(800) 222-NDRI (6374)